MedPath

Developing a Childhood Asthma Risk Passive Digital Marker

Not Applicable
Terminated
Conditions
Pediatric Asthma
Registration Number
NCT05826561
Lead Sponsor
Indiana University
Brief Summary

Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence are not widely used in practice.

The objective of the study is to determine the usability, acceptability, feasibility, and preliminary efficacy of the childhood asthma passive digital marker (PDM) among pediatricians. The study will include practicing pediatricians within the IU Health Network.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
34
Inclusion Criteria

• Practicing pediatricians within the IU Health Network

Exclusion Criteria

• Non-practicing pediatricians within the IU Health Network

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Perceived PDM acceptance8 to 12 months

Perceived PDM acceptance will be measured using a Behavioral Intention scale (BIS).

Perceived PDM usability8 to 12 months

Perceived Usability will be measured using a modified Simplified System Usability Scale (SUS).

Study feasibility8 to 12 months

Percent of successful study enrollment of eligible clinicians (\>80%)

Secondary Outcome Measures
NameTimeMethod
Prognostic accuracy3 to 12 months

% correct clinician predictions at pre and post test

Trial Locations

Locations (1)

Indiana University

🇺🇸

Indianapolis, Indiana, United States

Indiana University
🇺🇸Indianapolis, Indiana, United States
Arthur H Owora, PhD
Contact
405-312-3333
ahowora@iu.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.